As we pass the year-mark of the pandemic and inch closer to spring, people now more than ever are anxious to get vaccinated.
On March 8, 17.7% of the U.S. population had received at least one dose of the COVID-19 vaccine.
President Biden, meanwhile, recently promised vaccines for all American adults by mid-May—and, as you might have heard, there’s a new option available.
An Overview of the Johnson & Johnson Vaccine
At the end of February, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s Janssen Pharmaceuticals single-dose COVID-19 vaccine.
The company immediately began shipping the vaccine, with 100 million doses ready to be administered in the first half of 2021.
Public officials are excited about the single-shot vaccine. In Johnson & Johnson’s clinical trial, researchers found that the vaccine was 72% effective at preventing moderate to severe cases of COVID-19 in the United States.
Most importantly, it was found to prevent 100% of hospitalizations and deaths associated with the novel coronavirus. This means that no one who received the Johnson & Johnson vaccine was hospitalized or died from the virus within 28 days of being vaccinated.
Johnson & Johnson vs. Pfizer and Moderna
Regulators are excited about Johnson & Johnson’s COVID-19 vaccine.
Though clinical trial data reveals that Moderna and Pzifer-BioNTech can prevent 94% and 95%, respectively, of moderate to severe COVID-19 cases, experts claim we shouldn’t focus on those numbers.
What we should focus on, they say, is that Johnson & Johnson’s shot—like Moderna’s and Pfizer’s—can prevent the most severe outcomes of the virus without fail.
Basically, if you’re eligible for an appointment to receive the COVID-19 vaccine, you shouldn’t turn down the chance to receive one—no matter whose shot you’re getting. As celebrated Chief Medical Advisor Anthony Fauci says, “All three are good.”
Johnson & Johnson’s COVID-19 Vaccine: Additional Benefits
By receiving Johnson & Johnson’s single-dose vaccine, Americans can receive their shot, go home, and wait for the protective benefits to kick in without having to return for a second dose.
In addition, the Johnson & Johnson vaccine doesn’t have the same cold-storage requirements as the Moderna and Pfizer ones do—making it easier to transport and store.
This also makes the newly-approved vaccine ideal for mobile and drive-thru vaccination sites across the U.S. And when it comes to the COVID-19 vaccine, accessibility is key.
Have you received your COVID-19 vaccine? Please share your experiences in the comments below—or contact us to learn more about what Umbrella Security Services can do for your business.